Annis Gardner Whiting Capital Advisors, LLC Regeneron Pharmaceuticals, Inc. Transaction History
Annis Gardner Whiting Capital Advisors, LLC
- $355 Billion
- Q3 2024
A detailed history of Annis Gardner Whiting Capital Advisors, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Annis Gardner Whiting Capital Advisors, LLC holds 37 shares of REGN stock, worth $27,306. This represents 0.01% of its overall portfolio holdings.
Number of Shares
37
Previous 53
30.19%
Holding current value
$27,306
Previous $55.7 Million
30.18%
% of portfolio
0.01%
Previous 0.02%
Shares
5 transactions
Others Institutions Holding REGN
# of Institutions
1,531Shares Held
84.1MCall Options Held
1.22MPut Options Held
1.51M-
Vanguard Group Inc Valley Forge, PA9.32MShares$6.88 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$6.23 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY7.49MShares$5.53 Billion0.65% of portfolio
-
State Street Corp Boston, MA4.9MShares$3.62 Billion0.21% of portfolio
-
Capital World Investors Los Angeles, CA4.3MShares$3.17 Billion0.72% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $79.1B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...